Literature DB >> 20111660

Cervical cancer: a preventable death.

Nawal M Nour1.   

Abstract

Cervical cancer kills 260,000 women annually, and nearly 85% of these deaths occur in developing nations, where it is the leading cause of cancer deaths in women. Disparities of health and poverty play a large role in this high mortality rate. Whereas routine Papanicolaou and human papillomavirus (HPV) testing has dramatically reduced cervical cancer deaths in Western nations, without proper infrastructure, facilities, and medical training, the rates of cervical cancer in developing nations will remain high. Studies on HPV DNA testing and the low-technology method of "screen and treat" are promising. In addition, reducing the cost and increasing the availability of HPV vaccines in developing nations brings hope and promise to the next generation of women.

Entities:  

Keywords:  Cervical cancer; Human papillomavirus; Human papillomavirus DNA testing; Human papillomavirus vaccine

Year:  2009        PMID: 20111660      PMCID: PMC2812875     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN: 1941-2797


  16 in total

1.  Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.

Authors:  Rengaswamy Sankaranarayanan; Pulikkottil Okkuru Esmy; Rajamanickam Rajkumar; Richard Muwonge; Rajaraman Swaminathan; Sivanandam Shanthakumari; Jean-Marie Fayette; Jacob Cherian
Journal:  Lancet       Date:  2007-08-04       Impact factor: 79.321

2.  From India to the world--a better way to prevent cervical cancer.

Authors:  Mark Schiffman; Sholom Wacholder
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

3.  A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Ketayun A Dinshaw; Cedric Mahe; Kasturi Jayant; Surendra S Shastri; Sylla G Malvi; Roshini Chinoy; Rohini Kelkar; Atul M Budukh; Vijay Keskar; Raghevendra Rajeshwarker; Richard Muwonge; Shubhada Kane; Donald Maxwell Parkin; Madanmohan K Chauhan; Sangeetha Desai; Bernard Fontaniere; Lucien Frappart; Ashok Kothari; Eric Lucas; Nandkumar Panse
Journal:  Int J Cancer       Date:  2005-09-10       Impact factor: 7.396

4.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

Authors:  You-Lin Qiao; John W Sellors; Paul S Eder; Yan-Ping Bao; Jeanette M Lim; Fang-Hui Zhao; Bernhard Weigl; Wen-Hua Zhang; Roger B Peck; Ling Li; Feng Chen; Qing-Jing Pan; Attila T Lorincz
Journal:  Lancet Oncol       Date:  2008-09-19       Impact factor: 41.316

5.  Cost-effectiveness of cervical-cancer screening in five developing countries.

Authors:  Sue J Goldie; Lynne Gaffikin; Jeremy D Goldhaber-Fiebert; Amparo Gordillo-Tobar; Carol Levin; Cédric Mahé; Thomas C Wright
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 6.  A critical assessment of screening methods for cervical neoplasia.

Authors:  R Sankaranarayanan; L Gaffikin; M Jacob; J Sellors; S Robles
Journal:  Int J Gynaecol Obstet       Date:  2005-05       Impact factor: 3.561

Review 7.  Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings.

Authors:  M Jacob; F F Broekhuizen; W Castro; J Sellors
Journal:  Int J Gynaecol Obstet       Date:  2005-05       Impact factor: 3.561

8.  Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.

Authors:  L Kuhn; L Denny; A Pollack; A Lorincz; R M Richart; T C Wright
Journal:  J Natl Cancer Inst       Date:  2000-05-17       Impact factor: 13.506

9.  Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.

Authors:  Lynette Denny; Louise Kuhn; Michelle De Souza; Amy E Pollack; William Dupree; Thomas C Wright
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

10.  Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.

Authors:  Sue J Goldie; Meredith O'Shea; Mireia Diaz; Sun-Young Kim
Journal:  Reprod Health Matters       Date:  2008-11
View more
  26 in total

Review 1.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

2.  Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.

Authors:  Kathleen Lovgren; Amr S Soliman; Twalib Ngoma; Crispin Kahesa; Jane Meza
Journal:  Int J STD AIDS       Date:  2015-10-12       Impact factor: 1.359

3.  Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).

Authors:  Marcela Kazue Hassumi-Fukasawa; Fabiana Alves Miranda-Camargo; Bruna Riedo Zanetti; Denise Faria Galano; Alfredo Ribeiro-Silva; Edson Garcia Soares
Journal:  Pathol Oncol Res       Date:  2012-03-28       Impact factor: 3.201

Review 4.  IL-37: An anti-inflammatory cytokine with antitumor functions.

Authors:  Yu Mei; Haiyan Liu
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-22

5.  Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens.

Authors:  Paula Böttinger; Karin Schreiber; Elizabeth Hyjek; Thomas Krausz; Michael T Spiotto; Madeline Steiner; Christian Idel; Heather Booras; Gabriele Beck-Engeser; Jessie Riederer; Gerald Willimsky; Steven P Wolf; Theodore Karrison; Elizabeth Jensen; Ralph R Weichselbaum; Yusuke Nakamura; Poh Yin Yew; Paul F Lambert; Takeshi Kurita; Kazuma Kiyotani; Matthias Leisegang; Hans Schreiber
Journal:  Carcinogenesis       Date:  2020-11-13       Impact factor: 4.944

6.  Prevalence of human papilloma virus and their high-risk genotypes in Sri Lankan women.

Authors:  K A S N Shanaka; S Wilathgamuwa; Y I N S Gunawardene; R S Dassanayake
Journal:  Virusdisease       Date:  2018-02-15

7.  Vaginal Suppositories Containing SHetA2 to Treat Cervical Dysplasia: Pharmacokinetics of Daily Doses and Preliminary Safety Profile.

Authors:  Sanjida Mahjabeen; Manolya Kukut Hatipoglu; Stanley D Kosanke; David Garcia-Contreras; Doris M Benbrook; Lucila Garcia-Contreras
Journal:  J Pharm Sci       Date:  2020-02-27       Impact factor: 3.534

8.  Burden of Cervical Cancer in the Eastern Mediterranean Region During the Years 2000 and 2017: Retrospective Data Analysis of the Global Burden of Disease Study.

Authors:  Fereshteh Safaeian; Shidrokh Ghaemimood; Ziad El-Khatib; Sahba Enayati; Roksana Mirkazemi; Bruce Reeder
Journal:  JMIR Public Health Surveill       Date:  2021-05-12

9.  Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix.

Authors:  Kathleen P Saavedra; Priscilla M Brebi; Juan Carlos S Roa
Journal:  Clin Epigenetics       Date:  2012-08-31       Impact factor: 6.551

10.  Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey.

Authors:  Tomi F Akinyemiju
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.